Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies

Quantitative assessment of HER2 amplification in HER2-positive breast cancer: its association with clinical outcomes

(2015) Qijia Xuan et al.   BREAST CANCER RESEARCH AND TREATMENT

ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics

(2014) Carlos L. Arteaga et al.   CANCER CELL

Effect of p95HER2/611CTF on the Response to Trastuzumab and Chemotherapy

(2014) Josep Lluís Parra-Palau et al.   JNCI-Journal of the National Cancer Institute

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Gemcitabine Eliminates Double Minute Chromosomes from Human Ovarian Cancer Cells

(2013) Lisa Yu et al.   PLoS One

Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA

(2013) David A. Nathanson et al.   SCIENCE

The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells

(2012) Kristine Kleivi Sahlberg et al.   Molecular Oncology

Heterogeneity Maintenance in Glioblastoma: A Social Network

(2011) R. Bonavia et al.   CANCER RESEARCH

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

(2011) Naoki Niikura et al.   JOURNAL OF CLINICAL ONCOLOGY

HER2 Therapy — An Abundance of Riches

(2011) William J. Gradishar   NEW ENGLAND JOURNAL OF MEDICINE

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

(2010) Luca Gianni et al.   LANCET

Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes

(2009) E. A. Mittendorf et al.   CLINICAL CANCER RESEARCH

A Naturally Occurring HER2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and Metastasis

(2009) K. Pedersen et al.   MOLECULAR AND CELLULAR BIOLOGY